Vital Therapies®, Inc. is a biotherapeutic company developing a cell-based system for the treatment of liver failure. The Company’s lead product candidate, the ELAD® System, is an extracorporeal human allogeneic cellular liver treatment currently being studied in Phase III clinical trials for acute alcoholic hepatitis.
DDW Tracks Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases
Does your company only service US attendees? No